Evidence map›Paper›PMID 25318056›Full record

ArticleInternational journal of molecular sciences2014

Nanoparticle encapsidation of Flock house virus by auto assembly of Tobacco mosaic virus coat protein.

Payal D Maharaj, Jyothi K Mallajosyula, Gloria Lee, Phillip Thi, Yiyang Zhou, Christopher M Kearney, Alison A McCormick

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Molecular pharmaceutics · 2024
    Article
  6. Article
  7. Article
  8. Review
  9. Polymer-mediated gene therapy: Recent advances and merging of delivery techniques.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2020
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Payal D MaharajDepartment of Biological and Pharmaceutical Sciences, Touro University, Vallejo, CA 94594, USA. pamahara@utmb.edu.
Jyothi K MallajosyulaDepartment of Biological and Pharmaceutical Sciences, Touro University, Vallejo, CA 94594, USA. mjyothik@gmail.com.
Gloria LeeDepartment of Biological and Pharmaceutical Sciences, Touro University, Vallejo, CA 94594, USA. gloria.lee@tu.edu.
Phillip ThiDepartment of Biological and Pharmaceutical Sciences, Touro University, Vallejo, CA 94594, USA. philip.thi@tu.edu.
Yiyang ZhouDepartment of Biology, Biomedical Studies Program, Baylor University, Waco, TX 76706, USA. Yiyang_Zhou@baylor.edu.
Christopher M KearneyDepartment of Biology, Biomedical Studies Program, Baylor University, Waco, TX 76706, USA. Chris_Kearney@baylor.edu.
Alison A McCormickDepartment of Biological and Pharmaceutical Sciences, Touro University, Vallejo, CA 94594, USA. alison.mccormick@tu.edu.
Touro University California · USBaylor University · US

Funding

Adaptation of a Novel RNA virus for vaccine useR03AI099584 · NIAID · TOURO UNIVERSITY OF CALIFORNIA · PI MCCORMICK, ALISON ANNE · 2012 to 2013
$145k
NIAID NIH HHS AI099584-02NIAID NIH HHS R03 AI099584
6 · The paper itself

Abstract

Tobacco Mosaic virus (TMV) coat protein is well known for its ability to self-assemble into supramolecular nanoparticles, either as protein discs or as rods originating from the ~300 bp genomic RNA origin-of-assembly (OA). We have utilized TMV self-assembly characteristics to create a novel Flock House virus (FHV) RNA nanoparticle. FHV encodes a viral polymerase supporting autonomous replication of the FHV genome, which makes it an attractive candidate for viral transgene expression studies and targeted RNA delivery into host cells. However, FHV viral genome size is strictly limited by native FHV capsid. To determine if this packaging restriction could be eliminated, FHV was adapted to express enhanced green fluorescent protein (GFP), to allow for monitoring of functional FHV RNA activity. Then TMV OA was introduced in six 3' insertion sites, with only site one supporting functional FHV GFP expression. To create nanoparticles, FHV GFP-OA modified genomic RNA was mixed in vitro with TMV coat protein and monitored for encapsidation by agarose electrophoresis and electron microscopy. The production of TMV-like rod shaped nanoparticles indicated that modified FHV RNA can be encapsidated by purified TMV coat protein by self-assembly. This is the first demonstration of replication-independent packaging of the FHV genome by protein self-assembly.

Indexed as

AnimalsCapsidCapsid ProteinsCell LineCricetinaeGenetic VectorsGreen Fluorescent ProteinsNanoparticlesNodaviridaeRNA, ViralTobacco Mosaic VirusTransfectionCapsid ProteinsGreen Fluorescent ProteinsRNA, Viral

Identifiers

PMID25318056
PMCPMC4227231
OpenAlexW2167693661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.